Home  >  Products  >  SART3 (squamous cell carcinoma antigen recognized by T cells 3) Blocking Peptide (100ug)
SART3 (squamous cell carcinoma antigen recognized by T cells 3) Blocking Peptide (100ug)

SART3 (squamous cell carcinoma antigen recognized by T cells 3) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SART3 antibody (Catalogue #: ARP39128_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP39128
Size: 100 ug
Weight: 40kDa
Gene: 9733
Format: Lyophilized powder
Target: SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing.
See Full Product Listings >